FERRARI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.262
EU - Europa 265
AS - Asia 143
SA - Sud America 5
Totale 1.675
Nazione #
US - Stati Uniti d'America 1.261
IT - Italia 117
CN - Cina 92
TR - Turchia 43
GB - Regno Unito 35
UA - Ucraina 30
DE - Germania 24
SE - Svezia 18
PL - Polonia 13
BE - Belgio 12
FI - Finlandia 8
RU - Federazione Russa 4
BR - Brasile 3
IN - India 3
VN - Vietnam 3
FR - Francia 2
IR - Iran 2
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
NL - Olanda 1
PE - Perù 1
Totale 1.675
Città #
Fairfield 208
Woodbridge 140
Ann Arbor 119
Ashburn 115
Seattle 95
Ferrara 78
Houston 78
Cambridge 67
Wilmington 64
Chandler 63
Jacksonville 45
Izmir 43
Dearborn 42
New York 24
Princeton 23
Beijing 20
Shanghai 20
Nanjing 17
Warsaw 13
Brussels 12
Milan 10
Addison 9
Boardman 9
San Diego 9
London 7
Nanchang 7
Falls Church 5
Cagliari 4
Des Moines 4
Leawood 4
Shenyang 4
Augusta 3
Dong Ket 3
Ferrara di Monte Baldo 3
Grassano 3
Guangzhou 3
Jiaxing 3
Kunming 3
Norwalk 3
Padova 3
San Mateo 3
Tianjin 3
Auburn Hills 2
Bologna 2
Bremen 2
Changsha 2
Helsinki 2
Islington 2
Jinan 2
Juiz De Fora 2
Los Angeles 2
Mountain View 2
Prescot 2
Redwood City 2
San Giovanni Lupatoto 2
Somma Vesuviana 2
Tappahannock 2
Torino 2
Aberdeen 1
Amsterdam 1
Ardabil 1
Baotou 1
Belo Horizonte 1
Bonn 1
Chicago 1
Haikou 1
Hebei 1
Hefei 1
Krasnodar 1
Lima 1
Mumbai 1
Ningbo 1
Osimo 1
Pune 1
Redmond 1
Rockville 1
Sanming 1
Toronto 1
Udine 1
Ullersdorf 1
Washington 1
Xian 1
Xuzhou 1
Totale 1.448
Nome #
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 136
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 119
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 118
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 117
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 114
null 105
Pharmacological characterization of tachykinin tetrabranched derivatives 104
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 99
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 94
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 90
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 80
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 79
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 77
Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor 76
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides 64
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 56
Prevenzione e Cura della carenza di vitamina E nei pazienti colestatici: il tocofersolano (Vedrop) per via orale 52
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 40
Novel Mixed NOP/Opioid Receptor Peptide Agonists 36
In vitro and in vivo activity of cyclopeptide Dmt-c[D-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin 33
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 30
Pharmacological profile of nociceptin/orphanin FQ receptor – characterization of novel peptide and non peptide ligands 17
Totale 1.736
Categoria #
all - tutte 7.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019193 0 0 0 0 0 0 0 0 0 41 59 93
2019/2020468 57 11 23 51 43 70 64 42 53 29 12 13
2020/2021344 17 13 23 21 12 39 58 37 18 35 45 26
2021/2022200 13 9 3 20 5 20 18 14 10 23 10 55
2022/2023191 26 17 13 30 11 16 14 28 16 1 13 6
2023/2024131 14 20 4 8 10 35 11 24 4 1 0 0
Totale 1.736